Bid Publish Date
11-Nov-2025, 10:24 am
Bid End Date
24-Nov-2025, 11:00 am
Value
₹5,40,275
Location
Progress
RAQuantity
298693
Category
Diclofenac SR 100 mg tab
Bid Type
Two Packet Bid
The procurement is issued by the Indian Army (Department Of Military Affairs) for a broad spectrum of pharmaceuticals and related items, including essential amino acids IV infusions, tablets, syrups, injections, and topical preparations, with an estimated value of ₹540,274.65. Location: Pune, Maharashtra. The vendor must ensure products are not obsolete and have a minimum of 5 years residual market life. A data sheet must accompany the bid to verify technical parameters and prevent mismatches. Key differentiator is the requirement for manufacturer/OEM authorization and government-sector supply experience. Unique aspect includes handling hazardous items with proper MSDS labeling during dispatch. The bid emphasizes alignment with central/state government procurement norms and strict supplier eligibility.
EMD: amount and process not explicitly stated; bidders must seek explicit terms during bid
Delivery: contractual delivery terms governed by buyer rights to terminate for non-performance
Documentation: mandatory PAN, GSTIN, cancelled cheque, EFT mandate, data sheets
Experience: 3 years govt/PSU supply experience required for OEM or reseller
Hazardous goods: compliance with MSDS, labeling, batch/ manufacturing details during dispatch
Not explicitly stated; bidders should confirm EFT/Payment timeline and any advance or milestone payments with the Indian Army during bid clarification
Delivery commitments tied to contract; Buyer may terminate for delays or inability to deliver as per stipulations
Terminations and penalties may apply for non-delivery, defective material, or misrepresentation; exact LD rates not specified in given terms
3 years government/PSU supply experience for similar products
OEM authorization for distributors or direct OEM supply
Regular manufacturing/supply history with no end-of-life risk within 5 years
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Essential Amino Acids IV Infusion 200 ml containing LYSINE 10 to 25 mg ml and ARGININE 7 to 25 mg ml , VENLAFAXINE 75 MG TAB , Diclofenac SR 100 mg tab , SITAGLIPTIN PHOSPHATE 50 MG TAB , ACOTIAMIDE 100 MG TAB , Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg Sodium Citrate 50 to 85 mg per 5 ml bottle of 100 ml Syp , Acetylcysteine 1gm Inj , IVERMECTIN TAB 6MG , DANAZOL 100 MG CAP , LEVODOPA 200 MG plus CARBIDOPA 50 MG SR TAB , CALCIUM ACETATE 667 MG TAB , Faropenam 200 mg tab , RANOLAZINE 500 MG TAB , TAB EZETIMIBE 10 MG , Thyroxin Sodium 75 mcg Tab , DIETHYLCARBAMAZINE 50MG TAB , Nitroglycerine Glyceryltrinitrate 5 mg Inj , BRIVARACETUM 50 MG Tab , CLOTRIMAZOLE CREAM 1 percent TUBE OF 15 GM , LORAZEPAM 1 MG TAB
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Essential Amino Acids IV Infusion 200 ml containing LYSINE 10 to 25 mg ml and ARGININE 7 to 25 mg ml
Essential Amino Acids IV Infusion 200 ml containing LYSINE 10 to 25 mg ml and ARGININE 7 to 25 mg ml
VENLAFAXINE 75 MG TAB
VENLAFAXINE 75 MG TAB
Diclofenac SR 100 mg tab
Diclofenac SR 100 mg tab
SITAGLIPTIN PHOSPHATE 50 MG TAB
SITAGLIPTIN PHOSPHATE 50 MG TAB
ACOTIAMIDE 100 MG TAB
ACOTIAMIDE 100 MG TAB
Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg Sodium Citrate 50 to 85 mg per 5 ml bottle of 100 ml Syp
Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg Sodium Citrate 50 to 85 mg per 5 ml bottle of 100 ml Syp
Acetylcysteine 1gm Inj
Acetylcysteine 1gm Inj
IVERMECTIN TAB 6MG
IVERMECTIN TAB 6MG
DANAZOL 100 MG CAP
DANAZOL 100 MG CAP
LEVODOPA 200 MG plus CARBIDOPA 50 MG SR TAB
LEVODOPA 200 MG plus CARBIDOPA 50 MG SR TAB
CALCIUM ACETATE 667 MG TAB
CALCIUM ACETATE 667 MG TAB
Faropenam 200 mg tab
Faropenam 200 mg tab
RANOLAZINE 500 MG TAB
RANOLAZINE 500 MG TAB
TAB EZETIMIBE 10 MG
TAB EZETIMIBE 10 MG
Thyroxin Sodium 75 mcg Tab
Thyroxin Sodium 75 mcg Tab
DIETHYLCARBAMAZINE 50MG TAB
DIETHYLCARBAMAZINE 50MG TAB
Nitroglycerine Glyceryltrinitrate 5 mg Inj
Nitroglycerine Glyceryltrinitrate 5 mg Inj
BRIVARACETUM 50 MG Tab
BRIVARACETUM 50 MG Tab
CLOTRIMAZOLE CREAM 1 percent TUBE OF 15 GM
CLOTRIMAZOLE CREAM 1 percent TUBE OF 15 GM
LORAZEPAM 1 MG TAB
LORAZEPAM 1 MG TAB
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Essential Amino Acids IV Infusion 200 ml containing LYSINE 10 to 25 mg ml and ARGININE 7 to 25 mg ml | Essential Amino Acids IV Infusion 200 ml containing LYSINE 10 to 25 mg ml and ARGININE 7 to 25 mg ml | 120 | bott | [email protected] | 45 | |
| 2 | VENLAFAXINE 75 MG TAB | VENLAFAXINE 75 MG TAB | 800 | no | [email protected] | 45 | |
| 3 | Diclofenac SR 100 mg tab | Diclofenac SR 100 mg tab | 21,000 | no | [email protected] | 45 | |
| 4 | SITAGLIPTIN PHOSPHATE 50 MG TAB | SITAGLIPTIN PHOSPHATE 50 MG TAB | 65,400 | no | [email protected] | 45 | |
| 5 | ACOTIAMIDE 100 MG TAB | ACOTIAMIDE 100 MG TAB | 3,000 | no | [email protected] | 45 | |
| 6 | Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg Sodium Citrate 50 to 85 mg per 5 ml bottle of 100 ml Syp | Diphenhydramine 10 to 15 mg per 5 ml and Ammonium Chloride 100 to 150 mg Sodium Citrate 50 to 85 mg per 5 ml bottle of 100 ml Syp | 1,140 | bott | [email protected] | 45 | |
| 7 | Acetylcysteine 1gm Inj | Acetylcysteine 1gm Inj | 405 | vial | [email protected] | 45 | |
| 8 | IVERMECTIN TAB 6MG | IVERMECTIN TAB 6MG | 1,800 | no | [email protected] | 45 | |
| 9 | DANAZOL 100 MG CAP | DANAZOL 100 MG CAP | 2,500 | no | [email protected] | 45 | |
| 10 | LEVODOPA 200 MG plus CARBIDOPA 50 MG SR TAB | LEVODOPA 200 MG plus CARBIDOPA 50 MG SR TAB | 19,800 | no | [email protected] | 45 | |
| 11 | CALCIUM ACETATE 667 MG TAB | CALCIUM ACETATE 667 MG TAB | 20,400 | no | [email protected] | 45 | |
| 12 | Faropenam 200 mg tab | Faropenam 200 mg tab | 700 | no | [email protected] | 45 | |
| 13 | RANOLAZINE 500 MG TAB | RANOLAZINE 500 MG TAB | 25,500 | no | [email protected] | 45 | |
| 14 | TAB EZETIMIBE 10 MG | TAB EZETIMIBE 10 MG | 3,000 | no | [email protected] | 45 | |
| 15 | Thyroxin Sodium 75 mcg Tab | Thyroxin Sodium 75 mcg Tab | 66,000 | no | [email protected] | 45 | |
| 16 | DIETHYLCARBAMAZINE 50MG TAB | DIETHYLCARBAMAZINE 50MG TAB | 5,400 | no | [email protected] | 45 | |
| 17 | Nitroglycerine Glyceryltrinitrate 5 mg Inj | Nitroglycerine Glyceryltrinitrate 5 mg Inj | 528 | amp | [email protected] | 45 | |
| 18 | BRIVARACETUM 50 MG Tab | BRIVARACETUM 50 MG Tab | 45,000 | no | [email protected] | 45 | |
| 19 | CLOTRIMAZOLE CREAM 1 percent TUBE OF 15 GM | CLOTRIMAZOLE CREAM 1 percent TUBE OF 15 GM | 5,400 | tube | [email protected] | 45 | |
| 20 | LORAZEPAM 1 MG TAB | LORAZEPAM 1 MG TAB | 10,800 | no | [email protected] | 45 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Extended Deadline
24-Nov-2025, 11:00 am
Opening Date
24-Nov-2025, 11:30 am
Start
21-Mar-2026, 3:00 pm
End
26-Mar-2026, 1:00 pm
Duration: 118 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 18-11-2025 17:09:09 | |
| 2 | ********** Under PMA | - | 21-11-2025 10:42:28 | |
| 3 | ********** Under PMA | - | 21-11-2025 10:41:40 | |
| 4 | ********** Under PMA | - | 11-11-2025 15:46:03 | |
| 5 | ********** Under PMA | - | 19-11-2025 11:12:12 | |
| 6 | ********** Under PMA | - | 21-11-2025 10:24:33 | |
| 7 | ********** Under PMA | - | 13-11-2025 19:16:53 | |
| 8 | ********** Under PMA | - | 23-11-2025 20:38:19 | |
| 9 | ********** Under PMA | - | 13-11-2025 19:21:59 | |
| 10 | ********** Under PMA | - | 20-11-2025 14:13:24 | |
| 11 | ********** Under PMA | - | 17-11-2025 16:02:21 | |
| 12 | ********** Under PMA | - | 20-11-2025 12:26:13 | |
| 13 | ********** Under PMA | - | 19-11-2025 12:01:45 | |
| 14 | ********** Under PMA | - | 21-11-2025 10:58:57 | |
| 15 | ********** Under PMA | - | 19-11-2025 14:25:46 | |
| 16 | ********** Under PMA | - | 14-11-2025 10:33:18 | |
| 17 | ********** Under PMA | - | 19-11-2025 13:05:46 | |
| 18 | ********** Under PMA | - | 20-11-2025 18:48:42 | |
| 19 | ********** Under PMA | - | 18-11-2025 17:25:44 | |
| 20 | ********** Under PMA | - | 18-11-2025 19:06:12 | |
| 21 | ********** Under PMA | - | 20-11-2025 18:43:55 | |
| 22 | ********** Under PMA | - | 19-11-2025 16:34:51 | |
| 23 | ********** Under PMA | - | 18-11-2025 16:45:39 | |
| 24 | ********** Under PMA | - | 17-11-2025 12:06:49 | |
| 25 | ********** Under PMA | - | 20-11-2025 19:43:27 | |
| 26 | ********** Under PMA | - | 21-11-2025 10:39:20 | |
| 27 | ********** Under PMA | - | 20-11-2025 16:09:59 | |
| 28 | ********** Under PMA | - | 17-11-2025 16:14:10 | |
| 29 | ********** Under PMA | - | 20-11-2025 15:53:37 | |
| 30 | ********** Under PMA | - | 19-11-2025 18:02:03 |
Key insights about MAHARASHTRA tender market
Bidders must submit PAN, GSTIN, cancelled cheque, EFT Mandate, and Data Sheets for offered products. Ensure 3 years govt supply experience and OEM authorization if using distributors. Verify product non-obsolescence and match DS parameters to avoid rejection. Clarify any missing terms before submission.
Required documents include PAN Card, GSTIN, cancelled cheque, EFT Mandate certified by bank, Data Sheets for each product, OEM/authorisation proof, and evidence of 3 years govt/PSU supply experience. Also provide contract copies showing yearly quantities and deliveries.
Upload Data Sheets matching the offered product specifications. Data sheets must align with IS/ISO standards referenced in tender, include batch numbers, manufacturing date, shelf life, MSDS for hazardous items, and ensure no parameter mismatch to avoid bid rejection.
Bidders must demonstrate at least 3 years of regular manufacturing/supplying similar category products to central or state government organizations or PSUs, with contract copies for each year submitted as evidence during bid.
Delivery terms are governed by the buyer’s contract rights; delay or failure to deliver can trigger contract termination. Exact liquidated damages rates are not stated here; bidders should seek clarification and ensure robust delivery timelines in bid documents.
Yes. If bidding through authorized distributors, an OEM authorization/form with details (name, designation, address, email, phone) must accompany the bid to verify supplier legitimacy and product provenance.
For hazardous items, ensure compliance with transport/handling/safety regulations, include MSDS, batch numbers, manufacturing date, gross/net weight, shelf life, and proper hazard labeling on packaging during dispatch.
Treat ₹540,274.65 as the indicative contract value; align offered quantities, pricing, and delivery schedules to fit this budget. Ensure data sheets, certifications, and experience evidence justify the proposed pricing for government review.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS